News

Many patients with diabetic foot infections get unnecessary MRSA treatment


 

FROM PLOS ONE

References

Many patients with diabetic foot infections receive methicillin-resistant Staphylococcus aureus antibiotics unnecessarily, according to Kelly Reveles, PharmD, and her associates.

Among the 318 patients with diabetic foot infections (DFIs) in the study, S. aureus was the most common pathogen, accounting for 146 cases. MRSA accounted for 47 of S. aureus cases, and 15% of overall cases. Although MRSA accounted for a relatively small number of cases, MRSA antibiotics were administered to 86% of all patients, resulting in 71% of all patients receiving the treatment unnecessarily.

©Balkonsky/Thinkstock

Independent risk factors for MRSA DFI were male sex and bone involvement. Other risk factors included previous MRSA infection, more severe infection, and a higher white cell count. The most common comorbidities of DFI were hypertension, dyslipidemia, and obesity.

“The improper use of antibiotics unnecessarily exposes the patient to potential complications of the therapy. Furthermore, the overuse of antibiotics drives antimicrobial resistance and is likely to increase the health care burden,” the investigators wrote.

Find the full study in PLoS One (doi: 10.1371/journal.pone.0161658).

lfranki@frontlinemedcom.com

Recommended Reading

Underweight patients showed greater mortality with gram-negative bacteremia
MDedge Endocrinology
Diabetic foot ulcer: Early closure post debridement best
MDedge Endocrinology
ICAAC: 2015 brings three major systematic reviews of diabetic foot infection therapy
MDedge Endocrinology
Progress in treating diabetic foot osteomyelitis
MDedge Endocrinology
Sovaldi topped Medicare part D spending in 2014
MDedge Endocrinology
EHR Report: How Zika virus reveals the fault in our EHRs
MDedge Endocrinology
Hepatitis B vaccine immunogenic, safe in diabetes patients
MDedge Endocrinology
Novel vaccine scores better hepatitis B seroprotection in type 2 diabetes
MDedge Endocrinology
Infections, antibiotics more common in type 2 diabetes
MDedge Endocrinology
FDA rule will pull many consumer antibacterial soaps from market
MDedge Endocrinology